Why the study?
Does percutaneous balloon venoplasty and stenting resolve symptoms in patients with symptomatic subclavian vein occlusion following transvenous pacemaker or defibrillator implantation?
Does percutaneous balloon venoplasty and stenting resolve symptoms in patients with symptomatic subclavian vein occlusion following transvenous pacemaker or defibrillator implantation?
Answers are grounded in this paper and cite their sources.
Percutaneous venoplasty and stenting over existing transvenous leads can provide rapid, safe symptomatic relief in select patients with chronic cardiac device-related subclavian vein occlusion when balloon angioplasty alone fails due to fibrotic recoil.
Subclavian vein stenosis is a common, but usually asymptomatic, complication following cardiac device placement. In addition to reviewing the literature on incidence, pathogenesis and management options for this important clinical problem, we describe two cases of symptomatic subclavian vein occlusion following pacemaker/defibrillator placement and successful treatment with venoplasty and stenting.
No takes yet. Share an insight, caveat, or question.
O’Leary et al. (2015) conducted a review in Symptomatic subclavian vein occlusion following transvenous pacemaker or defibrillator placement (n=2). Percutaneous balloon venoplasty and stenting was evaluated on Resolution of arm swelling and subcutaneous venous collaterals at 1-month follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: